Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/SLA.0000000000001212 | DOI Listing |
Ann Surg
May 2017
Division of Cardiovascular Anesthesiology, Texas Heart Institute, Baylor St Luke's Medical Center, Houston, TX, Department of Anesthesiology, Baylor College of Medicine, Houston, TX Division of Cardiovascular Anesthesiology, Texas Heart Institute, Baylor St Luke's Medical Center, Houston, TX, Department of Anesthesiology, Baylor College of Medicine, Houston, TX Division of Cardiovascular Anesthesiology, Texas Heart Institute, Baylor St Luke's Medical Center, Houston, TX, Department of Anesthesiology, Baylor College of Medicine, Houston, TX.
Ann Surg
May 2017
Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China Department of Anesthesiology, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Ann Surg
December 2015
*Department of Anesthesiology, Baylor College of Medicine, Houston, TX †Department of Biostatistics and Epidemiology, Texas Heart Institute, Houston, TX ‡Division of Cardiovascular Anesthesiology, Texas Heart Institute, Baylor St. Luke's Medical Center, Houston, TX §Department of Cardiovascular Surgery, Texas Heart Institute, Houston, TX.
Objective: To determine whether preoperative aspirin-acetylsalicylic acid (ASA)-timing or dose independently affects 30-day all-cause mortality.
Background: Preoperative ASA administration is associated with reduced morbidity and mortality after coronary artery bypass graft (CABG). However, data are lacking regarding optimal timing and dosing of ASA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!